Vera Therapeutics, Inc. Variable Lease, Cost
Vera Therapeutics, Inc. (VERA) reported Variable Lease, Cost of $3.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-08-05
- Vera Therapeutics, Inc. variable lease, cost for the quarter ending 2025-06-30 was $3.00K, a 75.00% decline year-over-year.
- Vera Therapeutics, Inc. variable lease, cost for the quarter ending 2025-03-31 was $7.00K, a 41.67% decline year-over-year.
- Vera Therapeutics, Inc. variable lease, cost for the quarter ending 2024-06-30 was $12.00K.
- Vera Therapeutics, Inc. variable lease, cost for the quarter ending 2024-03-31 was $12.00K.
- Vera Therapeutics, Inc. variable lease, cost for fiscal 2024 was $45.00K, a 221.43% increase from fiscal 2023.
- Vera Therapeutics, Inc. variable lease, cost for fiscal 2023 was $14.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 12 month |
|---|---|---|---|
| 2025-06-30 | $3.00K 10-Q · filed 2025-08-05 | $10.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-07 | ||
| 2024-12-31 | $45.00K 10-K · filed 2025-02-28 | ||
| 2024-06-30 | $12.00K 10-Q · filed 2025-08-05 | $25.00K 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $12.00K 10-Q · filed 2025-05-07 | ||
| 2023-12-31 | $14.00K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |